Grunenthal Presents a New Website for the Topical Treatment of Postherpetic Neuralgia (PHN)
Grunenthal Presents a New Website for the Topical Treatment of Postherpetic Neuralgia (PHN)
AsiaNet 53113
AACHEN, Germany, May 22 /PRN=KYODO JBN/ --
Healthcare professionals who would like to know more about the topical
treatment of postherpetic neuralgia (PHN) can now find useful information
online. PHN is a chronic disabling pain condition with symptoms often described
as burning, stabbing, or shooting pain, and caused by a previous herpes zoster
infection (commonly known as shingles). The new website answers questions like
"Why is PHN often misdiagnosed?" "Which questions help making the correct
diagnosis?" and "What are effective, well tolerated and easy-to-use first-line
treatment options?" Please visit http://www.versatis.com for details.
About Gruenenthal
The Gruenenthal Group is an independent, family-owned, international
research-based pharmaceutical company headquartered in Aachen, Germany.
Building on its unique position in pain treatment, its objective is to become
the most patient-centric company and thus to be a leader in therapy innovation.
Gruenenthal is one of the last remaining five research-oriented pharmaceutical
companies with headquarters in Germany which sustainably invests in research
and development. The research and development costs amounted to a preliminary
of about 26 percent of revenues in 2012. Gruenenthal's research and development
strategy concentrates on selected fields of therapy and state-of-the-art
technologies. We are intensely focused on discovering new ways to treat pain
better and more effectively, with fewer side-effects than current therapies.
Altogether, the Gruenenthal Group has affiliates in 26 countries worldwide.
Gruenenthal products are sold in more than 155 countries and today approx.
4,400 employees are working for the Gruenenthal Group worldwide. In 2012,
Gruenenthal achieved revenues of EUR 973 mn. More information:
Embargo: This information is intended for healthcare professionals only.
Contact: Jeanette Huebsch, Senior Manager Versatis, Gruenenthal Europe &
Australia
Phone: +49-241-569-1487, email: jeanette.huebsch@grunenthal.com
SOURCE: Grunenthal GmbH
本プレスリリースは発表元が入力した原稿をそのまま掲載しております。また、プレスリリースへのお問い合わせは発表元に直接お願いいたします。
このプレスリリースには、報道機関向けの情報があります。
プレス会員登録を行うと、広報担当者の連絡先や、イベント・記者会見の情報など、報道機関だけに公開する情報が閲覧できるようになります。